Terry L. Murdock, Chief Operating Officer at G1 Therapeutics, Inc. (GTHX), sold 648 shares at $5.17 ($3K) on 2022-07-05, disclosed to the SEC on 2022-07-06.
Open-market sale of $3k GTHX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2024-01-08 | $12K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $3K | — | Filing → |
| GTHX | SELL | 2023-01-05 | $13K | — | Filing → |